-transparent.png){kind=logo}
Substituted 1,5-diaryl-3(4-chlorophenyl)-delta 2-pyrazolines were synthesized and evaluated for anticonvulsant activity. Most pyrazolines (100 mg/kg) provided 20-80% protection against pentylenetetrazol-induced convulsions in mice. All compounds inhibited rat brain mitochondrial monoamine oxidase (MAO) and succinic dehydrogenase (SDH) and exhibited low toxicity as reflected by approximate LD50 values (500 to greater than 1000 mg/kg) in mice.
Related Publications
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
July 1974,
Journal of pharmaceutical sciences,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
May 1977,
Biochemical pharmacology,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
January 1979,
General pharmacology,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
June 1960,
Project report. USAF School of Aviation Medicine,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
March 1978,
The Indian journal of medical research,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
June 1996,
Naunyn-Schmiedeberg's archives of pharmacology,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
June 1976,
Neuropharmacology,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
January 1981,
General pharmacology,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
November 1970,
Biochemical pharmacology,
N Soni, and
K Pande, and
R Kalsi, and
T K Gupta, and
S S Parmar, and
J P Barthwal
July 1968,
Enzymologia,
